Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 18 of 37, showing 5 Applications out of 183 total, starting on record 86, ending on 90

# Protocol No Study Title Investigator(s) & Site(s)

86.

ECCT/21/10/05   Lactolize Study
    Lactoferrin and Lysozyme supplementation for long-term diarrhea sequelae   
Principal Investigator(s)
1. Benson Ochieng Singa
Site(s) in Kenya
1. Awendo Sub-County Hospital (Migori county)
2. Homa Bay County Referral Hospital (Homa Bay county)
3. Isebania Sub-County Hospital (Migori county)
4. Kendu Adventist Hospital (Homa Bay county)
5. Kisii Teaching and Referral Hospital (Kisii county)
6. Mbita Sub-County Hospital (Homa Bay county)
7. Rongo Sub-County Hospital (Migori county)
 
View

87.

ECCT/21/09/08   GBT133_Inclacumab Open-Label
    An Open-Label Extension Study to Evaluate the Long-Term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial   
Principal Investigator(s)
1. Fredrick Sirwa Chite
2. Bernhards Ragama Ogutu
3. Videlis N Nduba
4. Prof Jessie N Githanga
Site(s) in Kenya
1. International Cancer Institute (ICI)-Eldorate (Uasin Gishu county)
2. KEMRI/CRDR (Nairobi City county)
3. KEMRI Siaya Clinical Research Annex (Siaya county)
4. Gertrude’s Children’s Hospital. (Nairobi City county)
5. Strathmore University Medical Centre (Nairobi City county)
 
View

88.

ECCT/21/09/04   Recombinant COVID-19 Vaccine
    A global multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to evaluate the efficacy, safety, and immunogenicity of recombinant COVID-19 vaccine (Sf9 cells) for the prevention of COVID-19 in adults aged 18 years and older            
Principal Investigator(s)
1. Sylvester Kimaiyo
Site(s) in Kenya
1. KAVI-Institute of Clinical Research (Nairobi City county)
2. Moi Teaching and Referral Hospital (Uasin Gishu county)
3. Kenya Medical Research Institute, Kilifi (Kilifi county)
 
View

89.

ECCT/21/09/01   Kuwa Free! - Live free!
    Co-benefits of co-delivery of long-acting antiretrovirals and contraceptives   
Principal Investigator(s)
1. Rena Patel
2. Edwin Were
Site(s) in Kenya
Moi Teaching and Referral Hospital
 
View

90.

ECCT/21/08/01   CARES
    Phase 3b, Randomized, Multicenter, Open-Label Study Evaluating the Efficacy, Safety,and Tolerability of Switching to Long-Acting Cabotegravir Plus Long-Acting Rilpivirine From Current Antiretroviral Regimen in HIV-1 Infected, Virologically Suppressed Adults in Sub-Saharan Africa.   
Principal Investigator(s)
1. JOSPHAT KOSGEI
Site(s) in Kenya
1. AMPATH Eldoret (Uasin Gishu county)
2. Aghakhan University (Nairobi City county)
3. Kericho KEMRI WRP CRC site (Kericho county)
 
View